title: Development of class I-directed lymphocytotoxic antibodies after liver transplantation.
authors.affiliation: Baylor University Medical Center, Dallas, TX 75246.
authors.forename: C F
authors.initials: CF
authors.lastname: Bryan
authors.forename: J T
authors.initials: JT
authors.lastname: Newman
authors.forename: R L
authors.initials: RL
authors.lastname: Tillquist
authors.forename: B
authors.initials: B
authors.lastname: Husberg
authors.forename: G B
authors.initials: GB
authors.lastname: Klintmalm
authors.forename: M J
authors.initials: MJ
authors.lastname: Stone
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000032:analysis*; D001402:B-Lymphocytes / Q000276:immunology; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D011947:Receptors, Antigen, B-Cell / Q000032:analysis; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000888:Antibodies, Anti-Idiotypic; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D011947:Receptors, Antigen, B-Cell